 lack correl histolog find respons metastat breast cancer retrospect analysi prognost role histolog find respons chemotherapi surviv patient metastat breast cancer histolog materi avail patient metastat breast cancer m.d anderson cancer center chemotherapi doxorubicin cyclophosphamid similar drug tamoxifen mainten cyclophosphamid methotrex year cumul doxorubicin dose histolog distribut infiltr ductal carcinoma invas lobular mix histolog mucin signet ring tubular papillari individu histolog type patient ductal nonduct group baselin patient characterist age perform statu estrogen-receptor statu hormon respons diseas extent level alkalin phosphatas bilirubin lactat dehydrogenas similar group patient nonduct histolog metastat site patient hemoglobin mg/dl albumin mg/dl nonduct group patient factor impact result respons rate complet partial ductal group respons rate complet partial nonduct group time initi chemotherapi progress ident month group surviv initi chemotherapi differ month ductal month nonduct studi author histolog find bear patient respons metastat breast cancer